|Articles|February 4, 2009
Spectral domain OCT for drusen evaluation
Spectral domain optical coherence tomography for quantitative evaluation of drusen and associated structural changes in non-neovascular age-related macular degeneration
Advertisement
Please click
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
3
Opus Genetics reaches FDA alignment on phase 3 registrational design for OPGx-LCA5 gene therapy
4
Port Delivery System Therapies in Retinal Vascular Diseases
5


















